VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LIXT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LIXTLixte Biotechnology Holdings, Inc.
$7.21$79M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLIXTQuarterly Balance Sheet

Lixte Biotechnology Holdings, Inc. (LIXT) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Lixte Biotechnology Holdings, Inc. (LIXT) quarterly balance sheet — complete assets, liabilities & equity history

LIXT Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Total Current Assets3.41M5.18M5.43M989.75K1.51M1.15M1.69M2.67M3.59M4.31M5.23M3.02M4.33M5.56M6.82M8.02M4.11M5.09M6.31M7.24M
Cash & Short-Term Investments3.25M5.11M5.34M887.21K1.38M1.04M1.64M2.6M3.41M4.2M5.11M2.91M4.09M5.35M6.56M7.74M3.78M4.82M5.96M6.8M
Cash Only3.25M5.11M2.89M887.21K1.38M1.04M1.64M2.6M3.41M4.2M5.11M2.91M4.09M5.35M6.56M7.74M3.78M4.82M5.96M6.8M
Short-Term Investments002.45M00000000000000000
Accounts Receivable00000000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets0000000078.02K078.02K49.56K131.19K0147.02K147.02K147.02K150.24K32.22K44.87K
Total Non-Current Assets7.46M7.56M0198.83K006.93K000078.02K000010.91K026.38K323.33K
Property, Plant & Equipment850.13K7.56M000000000000000000
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets6.61M00198.83K006.93K000078.02K000010.91K026.38K323.33K
Total Assets10.87M12.73M5.43M1.19M1.51M1.15M1.7M2.67M3.59M4.31M5.23M3.1M4.33M5.56M6.82M8.02M4.12M5.09M6.33M7.24M
Asset Turnover--------------------
Asset Growth %617.55%1011.62%220.4%-55.44%-57.81%-73.41%-67.6%-13.81%-17.12%-22.52%-23.24%-61.43%5.18%9.18%7.67%10.79%-47.81%-2.59%364.89%282.85%
Total Current Liabilities1.22M1.33M521.42K537.12K355.1K318.28K328.96K421.46K462.84K313.86K311.74K402.61K249.99K395.76K408.33K531.54K644.59K302.93K258.7K376.33K
Accounts Payable391.08K436.48M235.9K92.15K112.48K83.21K72.86K131.4K207.87K120.51K177.28K366.53K178.66K183.75K252.43K337.02K336.99K193.47K232.02K162.45K
Days Payables Outstanding--------------------
Short-Term Debt595.42K69.07K000000000000000000
Deferred Revenue (Current)238.44K232.14K235.16K256.15K242.62K235.08K256.1K290.06K0157.1K036.09K0165.02K000026.68K213.88K
Other Current Liabilities0-436.05M50.37K00000216.15K090.56K026.36K0100.93K158.83K275.1K76.96K00
Current Ratio2.78x3.88x10.42x1.84x4.26x3.60x5.13x6.33x7.75x13.73x16.79x7.49x17.32x14.05x16.70x15.10x6.37x16.81x24.38x19.25x
Quick Ratio2.78x3.88x10.42x1.84x4.26x3.60x5.13x6.33x7.75x13.73x16.79x7.49x17.32x14.05x16.70x15.10x6.37x16.81x24.38x19.25x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities461.77K438.96K000000000000000000
Long-Term Debt461.77K0000000000000000000
Capital Lease Obligations00000000000000000000
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities0438.96K000000000000000000
Total Liabilities1.69M1.77M521.42K537.12K355.1K318.28K328.96K421.46K462.84K313.86K311.74K402.61K249.99K395.76K408.33K531.54K644.59K302.93K258.7K376.33K
Total Debt1.06M664.49K000000000000000000
Net Debt-2.19M-4.44M-2.89M-887.21K-1.38M-1.04M-1.64M-2.6M-3.41M-4.2M-5.11M-2.91M-4.09M-5.35M-6.56M-7.74M-3.78M-4.82M-5.96M-6.8M
Debt / Equity0.12x0.06x------------------
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--676.29x-4442.69x-427.55x-225.33x-138.42x-938.97x-242.36x-134.17x-101.12x-3650.47x-855.45x-353.22x-449.14x-696.50x-2465.19x-663.36x-453.01x--2050.08x
Total Equity9.18M10.96M4.91M651.46K1.16M827.22K1.37M2.25M3.13M3.99M4.92M2.69M4.08M5.17M6.41M7.49M3.47M4.79M6.07M6.87M
Equity Growth %691.85%1225.11%259.36%-71%-62.92%-79.29%-72.23%-16.58%-23.39%-22.66%-23.21%-64.06%17.5%7.83%5.54%9.12%-54.59%-4.42%432.45%309.24%
Book Value per Share0.840.230.800.240.470.370.611.001.391.782.371.622.453.103.854.622.533.484.425.04
Total Shareholders' Equity7.95M9.66M4.91M651.46K1.16M827.22K1.37M2.25M3.13M3.99M4.92M2.69M4.08M5.17M6.41M7.49M3.47M4.79M6.07M6.87M
Common Stock1.16K8795702762682252252252252252251661.67K1661.66K1.66K1.37K1.37K1.37K1.37K
Retained Earnings-60M-58.08M-55.53M-53.55M-52.78M-52.07M-51.45M-50.46M-49.45M-48.48M-47.45M-46.43M-44.76M-43.39M-41.76M-40.29M-38.74M-37.08M-35.05M-33.81M
Treasury Stock00000000000000000000
Accumulated OCI00000000000000000000
Minority Interest1.23M1.3M000000000000000000